Pharmaceutical Technology

JUNE 29, 2022

Specialty enzymes are proteins that can act as very specific biocatalysts to accelerate reactions and produce the desired target molecule in pharmaceuticals,” explains Kristoffer Laursen, Head of R&D at Novo Nordisk Pharmatech. “In In the evolving biotechnology industry, enzymes are important process aids.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295

pharmaphorum

FEBRUARY 28, 2022

Biocon’s partnership with Mylan – which merged with Pfizer’s Upjohn to form Viatris in 2020 – dates back more than a decade and has generated a number of biosimilars including insulin analogues, antibodies and recombinant proteins.

Insulin 102

Insulin Production Marketing Engineer 102

The Pharma Data

NOVEMBER 2, 2020

On average, people started eating fewer calories after a week, and saw their “good” HDL cholesterol increase while their levels of “bad” LDL cholesterol, insulin and triglycerides all fell. So, Arora and his colleagues there developed a lab-engineered antibody that essentially mimics the hormone.

Antibody 52

Antibody Drugs Hormones Insulin 52

Trialfacts

NOVEMBER 26, 2023

In summary, the main question that we want to answer with this study is: “Does lifting light weights in older men and women while consuming dairy protein, promote glycemic response, muscle gains and improve the ability to get around?” Why Participate? Participants will receive a free consultation with a nutritionist. William McMaster.

Research 52

Research Protein Insulin Allergies 52

XTalks

JUNE 12, 2023

Internationally, Medtronic expanded its MiniMed 780G insulin pump and Guardian 4 sensor. The company received FDA clearance for its SmartSpeed MR acceleration software, which introduces AI data collection algorithms to Philips’ existing Compressed SENSE MR engine. It also plans to launch these products in the US.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

Roots Analysis

SEPTEMBER 9, 2024

Over the years, pharmaceutical companies have shifted their priorities from traditional interventions towards more advanced pharmacological strategies, such as protein therapeutics. Further, $400 billion is the anticipated sales of protein-based therapeutics in 2023. The mRNA is then translated into to form functional proteins.

Protein 40

Protein Gene Production DNA 40

The Pharma Data

JULY 15, 2021

Protomer’s proprietary peptide- and protein-engineering platform is used to identify and synthesize molecules that can sense glucose or other endogenous modulators of protein activity. The potential value of the transaction is over $1 billion, with successful achievement of future development and commercial milestones.

Insulin 52

Insulin Protein Engineer Development 52